Skip to content
HowShorted

Ocugen, Inc. short interest in 2022

In 2022, Ocugen, Inc.'s disclosed short interest ran from 27.26% of shares outstanding on 14 Jan 2022 to 18.57% on 30 Dec 2022, a change of -8.69 percentage points. The year's high was 27.73% on 31 Mar 2022 and its low 18.43% on 30 Nov 2022, averaging 23.63% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.76 days on 30 Nov 2022. Full history: Ocugen, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Ocugen, Inc. in 2022

2022 in figures

Start of year
27.26% (14 Jan 2022)
End of year
18.57% (30 Dec 2022)
Change
-8.69 pp
High
27.73% (31 Mar 2022)
Low
18.43% (30 Nov 2022)
Average
23.63%
Highest days to cover
12.76 (30 Nov 2022)
SEC filings marked
8

Every report in 2022

Ocugen, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202227.26%4.52
31 Jan 202227.58%4.47
15 Feb 202227.37%6.95
28 Feb 202225.75%2.38results (8-K), 10-K filed
15 Mar 202224.17%3.99
31 Mar 202227.73%4.32
14 Apr 202227.06%7.69
29 Apr 202227.17%8.51
13 May 202226.83%7.3510-Q filed, results (8-K)
31 May 202227.69%9.06
15 Jun 202225.36%7.65
30 Jun 202225.29%7.83
15 Jul 202225.01%9.03
29 Jul 202225.72%11.48
15 Aug 202222.66%9.6210-Q filed, results (8-K)
31 Aug 202220.94%9.15
15 Sep 202218.97%8.63
30 Sep 202220.22%7.05
14 Oct 202219.95%9.56
31 Oct 202219.98%10.08
15 Nov 202218.97%7.5110-Q filed, results (8-K)
30 Nov 202218.43%12.76
15 Dec 202218.52%9.50
30 Dec 202218.57%7.92

See also: Ocugen, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.